SCNI — Scinai Immunotherapeutics Ltd.

—
Nasdaq · Health Care · Biotechnology · CIK 1611747 ·
Last close
$0.37
Market Cap
$252.4K
52W High
$13.00
52W Low
$0.36
ADV30
2,320,735
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,856,000 -601,000 -1,950,000 -1,967,000 15,698,000 1,712,000 4,984,000
Jun 2026 460,000 -1,252,000 -2,146,000 -2,003,000 17,175,000 2,654,000 5,443,000
Mar 2026 489,000 -1,118,000 -2,467,000 3,577,000 17,588,000 2,963,000 5,827,000
Dec 2025 — — — — 11,626,000 1,661,000 3,523,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-6,495,000
Investing CF
$2,624,000
Financing CF
$3,907,000
CapEx
$-127,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.38
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-124,272,000
Inventory
—
Receivables
$635,000
ST Investments
—
EBIT TTM
$-1,975,000
Pretax Income TTM
$-2,560,000
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,487,000
EBITDA
$-6,636,000
Free Cash Flow
$-3,657,250
Enterprise Value
$7,499,236
Total Cash
$2,654,000
Total Debt
$3,580,000
Shares Out
677,581
Trailing EPS
$28.07
Book Value
$10.71
ROE
-26.5%
ROA
-36.2%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,311,000 -7,542,000 -8,307,000 11,600,000 3,523,000 8,103,000 -6,031,000
Dec 2024 658,000 -8,638,000 4,796,000 13,400,000 3,470,000 9,977,000 -6,335,000
Dec 2023 0 -9,706,000 -6,500,000 17,500,000 22,041,000 -4,569,000 -9,382,000
Dec 2022 0 -11,061,000 -5,796,000 27,100,000 28,827,000 -1,760,000 -7,265,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$23,292,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
CERO CERO THERAPEUTICS HOLDINGS, INC. $290.1K $0.00 —
CPMV Mosaic ImmunoEngineering Inc. $550.4K $0.08 —
GPLB Green Planet Bio Engineering Co. Ltd. $580.2K $0.03 —
SLXN Silexion Therapeutics Corp $1.07M $1.65 —
AGTX Agentix Corp. $1.35M $0.03 —

News headlines (Yahoo Finance, 1h cache)

Scinai Reports Significant Revenue Growth in First Nine Months of 2026 as CDMO Business Expands
2026-11-05 13:00 · Yahoo
Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing
2026-10-20 12:35 · Yahoo
Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement
2026-10-16 12:00 · Yahoo
Scinai Immunotherapeutics Announces $4.0 Million Financing Through a Private Placement and Warrant Inducement
2026-10-14 12:00 · Yahoo
Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement
2026-10-13 11:00 · Yahoo
Scinai Regains Compliance with Nasdaq Minimum Bid Price Requirement
2026-09-21 11:00 · Yahoo
Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business
2026-09-08 13:15 · Yahoo
Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum
2026-08-24 11:00 · Yahoo
Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration
2026-08-10 10:34 · Yahoo
Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives
2026-06-10 11:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.